Could Ki-67 redefine pulmonary carcinoid grading? This study proposes a practical 3-tier classification: 🟢 NET G1 → Ki-67 ≤6% 🟠 NET G2 → Ki-67 6–16% 🟣 NET G3 → Ki-67 >16% Mitotic count refines the intermediate group, while necrosis may be less prognostically relevant than previously thought. A compelling move beyond the TC vs AC dichotomy. #LungNETs #ThoracicPathology #LungCancer #Neuroendocrine #MedEd #OncoTwitter #onctwitter @OncoDailyGI @OncoThor

Congratulations to @HuiYu95592845 Hui Yu, MD, PhD, of @CUAnschutz on her NETRF Mentored Research Award award for her research exploring how DIPNECH can progress to lung neuroendocrine tumors. Learn more: ow.ly/HQY950YzPya #DIPNECH #LungNETs #NETRFGrantee

NCAN Miami 2026 – a collaboration between @netcanceraware & @SylvesterCancer – successfully brought together multidisciplinary experts, patients & advocates to advance care in neuroendocrine tumors (NETs). Honored to co-chair with @TVaghaiwalla and had the pleasure of speaking on Lung NETs and the evolving role of thoracic oncology. Insightful discussions across surgery, IR, and clinical trials, along with a dynamic tumor board and powerful patient voices. Grateful to all speakers, panelists & patient advocates for sharing their journeys. #LungNETs #ThoracicOncology #ClinicalTrials #PrecisionOncology #NCAN

@CureNETs is excited to share new NETRF Grant Recipient ChristinKuo @StanfordCEPB🔬Dr. Kuo’s team will compare normal lung neuroendocrine cells with lungNET cells.This research could improve diagnosis and treatment of #lungNETs. #neuroendocrinecancer #https://tinyurl.com/f55ef88v

Thrilled to announce our #ReviewArticle in @TheLancetOncol on #Pulmonary #Neuroendocrine #Neoplasms– hard-to-treat cancer type with a pressing need for better strategies. This comprehensive review covers: ✅ Molecular Landscape ✅ Therapeutic challenges ✅ Diagnosis & management strategies 🎉🎆Kickstarting 2025 with teamwork and dedication to advancing care for #LungNETs. - Honored to collaborate with an exceptional team, including @SWOG investigators- @NaglaAKarimMD @fred_hirsch @thenasheffect @Sonampuri @DrSukrithan @StephensonCC and others. - Thankful to the @TheLancetOncol editorial team for a fantastic publication experience. Let’s tackle these complex diseases with precision, not borrowed solutions! Read it here: thelancet.com/journals/lanon… #LCSM #OncoAlert #LungCancer #NETs #NeuroendocrineTumors #Clinicaltrial #precisionmedicine @oncodaily @OncLive @lcsmchat @IcahnMountSinai @TischCancer @MoffittNews @OhioStateMedOnc

@CureNETs is proud to have supported this work and excited by the results.Research👉discoveries👉better treatments for #neuroendocrinecancer.Congrats @yotam_d and team! #CancerResearch #LungNETs @marklewismd @SuzanneRLudlow @Globeseek

On #WorldLungCancerDay, @CureNETs is reaching out to those who have been diagnosed with #neuroendocrinecancer of the lung. Often overlooked and misdiagnosed. Find resources on our website, including our updated #NETWise on LungNETs: netrf.org/podcast/netwise-ep….

Had a great time recording this update for NETWise series. Please check it out!We discuss Typical Carcinoid, Atypical Carcinoid, LCNEC and SCLC. We also touch a bit on novel treatments on the horizon. Hope you like it. Nicely done NETRF!! #LungNETs 🦓 @SylvesterCancer @CureNETs

Thank you for highlighting @n8pennell! In this review, we unravel the biology and molecular features of SCLC and other lung neuroendocrine neoplasms and the potential therapeutic implications for #EdBook #ASCO23 #LCSM #LungNETS @IARCWHO @CancersRare

Also @PheoPara and @LMFendo for help on parapheo and @ClaireMulveyMD for help on #lungnets

So proud and grateful to receive support from NETRF! Our @CancersRare project at @IARCWHO aims to improve the diagnosis and treatment of #LungNETS patients netrf.org/research/reconcili… #NeuroendocrineCancer

..."I don't have asthma. But I do have Lung #Neuroendocrine Cancer." Meet Lisa, our new Ambassador and read her story to diagnosis here: neuroendocrinecancer.org.uk/… @BTOGORG @UKlungcancer @asthmalunguk @Roy_Castle_Lung @LCN_UK #LungNets @LungAmbition @TheChristieNHS

Lung NET expert @SukiPaddaMD will join us in just 2 days for a presentation and live Q&A. Dr. Padda will cover all lung NENs, including both NET & NEC. The live webinar is this Thursday @ 12pm PT. Register here: bit.ly/LACNETS_Aug2022 #NETCancer #NETs #LungNETs #NENs #NEC #NET

Are you living w/ lung NET or know someone who does? Lung NET expert @SukiPaddaMD of @CSCancerCare will give an update on #LungNETs at our upcoming webinar. Lung NETs is a less common type of NET so we wanted to dedicate this webinar to this topic. bit.ly/LACNETS_Aug2022

We are live talking about #lungnets with @UCSFCancer @ClaireMulveyMD fb.watch/cOxTe4DwAT/ Join us or watch the replay

Difficult to complete with my NSCLC colleagues ;) but happy to discuss some advances in our understanding of Lung NETs, new WHO classification and future directions and supportive data on systemic agents used for TC and AC and new trials. #lung cancer #LungNETs

Don't forget to register! nanets.net/component/civicrm… We will recap and provide updates for the 2021 CommNETs/NANETS Guidelines for the Diagnosis and Management of Patients with LungNETs and the 2020 NANETS Consensus Guidelines for Surveillance and Medical Management of pNETs.

#FBF video - In June 2020, lung NET expert Dr. Robert Ramirez gave a presentation on lung NETs and the important steps one needs to take when given this rare diagnosis. Watch Dr. Ramirez's full presentation here: youtu.be/sZIVip3CIxI?t=1694 #LungNETs #NETs #NETcancer #NETpatient

@FCLynnette presenting our ongoing work on the molecular characterization of lung supra-#carcinoids during the 2020 NETRF @CureNETs Virtual Research Symposium: youtu.be/zB4czsxUsBE?t=1929 #NeuroendocrineCancer #LungNETS

💯 #lungNETs one of the main NET secreting a lot of serotonin